Ultrahuman M2 Live brings affordable metabolic health tracking to US consumers at $99 per month

Ultrahuman M2 Live Expands Access to Continuous Glucose Monitor Technology

Ultrahuman has launched M2 Live in the United States, marking a significant expansion in consumer access to metabolic health monitoring 1

1

. The platform integrates glucose data from Abbott's Lingo CGM, an over-the-counter continuous glucose monitor that requires no prescription, allowing non-diabetic consumers to track how food, exercise, stress, and sleep affect their bodies in real time 2

2

.

With subscriptions starting at $99 per month and individual sensors priced at $129, Ultrahuman M2 Live represents a more affordable entry point for adults seeking to understand their metabolic health 1

1

. Each Lingo biosensor can be worn for up to 14 days, providing continuous glucose tracking throughout the day 2

2

. The platform is designed for adults aged 18 years and older who are not using insulin and want to monitor how daily habits influence their glucose levels.

Real-Time Metabolic Health Tracking Powered by Jade AI Biointelligence System

What sets Ultrahuman M2 Live apart from traditional glucose monitoring solutions is its integration of multiple health data streams. The platform combines glucose readings from Abbott's Lingo CGM with information collected from the Ultrahuman Ring and Blood Vision service, which analyzes more than 100 blood biomarkers 1

1

. This allows users to view glucose patterns alongside sleep quality, activity levels, recovery, stress, heart rate variability, and body temperature.

At the core of this experience is the Jade AI biointelligence system, which analyzes health data in real time and helps explain why glucose levels rise or fall by connecting them to lifestyle factors such as meals, exercise routines, sleep habits, and recovery patterns 2

2

. This AI-powered approach transforms raw glucose data into actionable health insights that users can apply to their daily lives.

Personalized Nutrition Insights and Metabolic Score Tracking

Ultrahuman M2 Live includes several tools designed to make glucose data more accessible and actionable. The platform features a daily Metabolic Score ranging from 0 to 100 that reflects overall glucose regulation 1

1

. According to the company, this Metabolic Score tracking has been clinically validated through a multi-center study published in Nature, demonstrating its ability to distinguish between non-diabetic and prediabetic individuals 1

1

.

The platform also provides personalized nutrition insights through Food Scores that show how specific foods affect glucose levels, along with glucose spike alerts that notify users when their blood sugar rises rapidly 2

2

. For those focused on exercise, Fueling Scores offer workout-specific guidance. Users also gain access to OGDb, described as the world's largest open glucose database containing anonymized food-response and glucose-related data 1

1

.

Addressing the Metabolic Health Crisis for Prediabetes and Beyond

The launch comes at a critical time for American health. According to Ultrahuman, only one in eight US adults is metabolically healthy, contributing to conditions such as Type 2 diabetes and cardiovascular disease 1

1

. The platform is available not only to wellness-focused consumers but also to people with prediabetes who are interested in improving their overall metabolic health before serious conditions develop.

Ultrahuman points to recent collaborations with Stanford University, Bangor University, La Trobe University, and the Mayo Clinic as part of its broader metabolic health research efforts 1

1

. These partnerships underscore the scientific foundation behind the platform and suggest ongoing research may further validate and expand its capabilities.

As over-the-counter continuous glucose monitors become more widely available and wearable technology continues to advance, platforms like Ultrahuman M2 Live could help bring biomarker testing and comprehensive health monitoring to a much broader audience. The platform will be available through Ultrahuman's website in the coming weeks 1

1

.